About Recessive mitochondrial ataxia syndrome
Recessive mitochondrial ataxia syndrome is a rare disease catalogued by Orphanet (ORPHA:94125). It is associated with the POLG gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Recessive mitochondrial ataxia syndrome trials.
Search ClinicalTrials.gov for "Recessive mitochondrial ataxia syndrome" or filter by Orphanet code ORPHA:94125 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Recessive mitochondrial ataxia syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Recessive mitochondrial ataxia syndrome. Updated daily.